200 related articles for article (PubMed ID: 15984513)
1. [Postoperative adjuvant chemotherapy for non-small cell lung cancer].
Okamoto T; Ichinose Y
Gan To Kagaku Ryoho; 2005 Jun; 32(6):765-9. PubMed ID: 15984513
[TBL] [Abstract][Full Text] [Related]
2. [Adjuvant chemotherapy for non-small cell lung cancer].
Okamoto T; Ichinose Y
Gan To Kagaku Ryoho; 2006 Dec; 33(13):1985-90. PubMed ID: 17197740
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant Chemotherapy in Resected Stage II Non-small Cell Lung Cancer: Evaluating the Impact of Dose Intensity and Time to Treatment.
Ramsden K; Laskin J; Ho C
Clin Oncol (R Coll Radiol); 2015 Jul; 27(7):394-400. PubMed ID: 25800720
[TBL] [Abstract][Full Text] [Related]
4. Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJSG).
Wada H; Miyahara R; Tanaka F; Hitomi S
Eur J Cardiothorac Surg; 1999 Apr; 15(4):438-43. PubMed ID: 10371118
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy in resected non-small cell lung cancer.
Cangiano R
Rays; 2004; 29(4):435-7. PubMed ID: 15852732
[TBL] [Abstract][Full Text] [Related]
6. [Adjuvant chemotherapy for non-small cell lung cancer].
Otake Y; Tanaka F; Wada H; Hitomi S
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1245-51. PubMed ID: 9279343
[TBL] [Abstract][Full Text] [Related]
7. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
Imaizumi M;
Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
[TBL] [Abstract][Full Text] [Related]
8. Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).
Tanaka F; Miyahara R; Ohtake Y; Yanagihara K; Fukuse T; Hitomi S; Wada H
Eur J Cardiothorac Surg; 1998 Sep; 14(3):256-62; discussion 263-4. PubMed ID: 9761434
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of postoperative adjuvant therapy for resected non-small cell lung cancer--an evidence-based review].
Tanaka F; Wada H
Gan To Kagaku Ryoho; 2006 Mar; 33(3):300-6. PubMed ID: 16531708
[TBL] [Abstract][Full Text] [Related]
10. [Medical treatment for stage III non-small-cell lung cancer (NSCLC)].
Okamoto H; Watanabe K
Gan To Kagaku Ryoho; 2007 Jun; 34(6):841-8. PubMed ID: 17565244
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery.
Wada H; Hitomi S; Teramatsu T
J Clin Oncol; 1996 Apr; 14(4):1048-54. PubMed ID: 8648356
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy for completely resected non-small-cell lung cancer.
Suehisa H; Toyooka S
Acta Med Okayama; 2009 Oct; 63(5):223-30. PubMed ID: 19893597
[TBL] [Abstract][Full Text] [Related]
13. A retrospective comparison of adjuvant chemotherapeutic regimens for non-small cell lung cancer (NSCLC): paclitaxel plus carboplatin versus vinorelbine plus cisplatin.
Chang WJ; Sun JM; Lee JY; Ahn JS; Ahn MJ; Park K
Lung Cancer; 2014 Apr; 84(1):51-5. PubMed ID: 24521819
[TBL] [Abstract][Full Text] [Related]
14. A feasibility study of postoperative adjuvant therapy of carboplatin and weekly paclitaxel for completely resected non-small cell lung cancer.
Yamashita Y; Kataoka K; Ishida T; Matsuura M; Seno N; Mukaida H; Miyahara E; Miyata Y; Okita R; Shimizu K; Watari M; Okumichi T; Okada M
J Thorac Oncol; 2008 Jun; 3(6):612-6. PubMed ID: 18520800
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small cell lung cancer.
Park SY; Lee JG; Kim J; Byun GE; Bae MK; Lee CY; Kim DJ; Chung KY
J Cardiothorac Surg; 2013 Jun; 8():151. PubMed ID: 23759129
[TBL] [Abstract][Full Text] [Related]
16. Postoperative adjuvant therapy for completely resected early-stage non-small cell lung cancer.
Kato H; Tsuboi M; Kato Y; Ikeda N; Okunaka T; Hamada C
Int J Clin Oncol; 2005 Jun; 10(3):157-64. PubMed ID: 15990962
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.
Arriagada R; Bergman B; Dunant A; Le Chevalier T; Pignon JP; Vansteenkiste J;
N Engl J Med; 2004 Jan; 350(4):351-60. PubMed ID: 14736927
[TBL] [Abstract][Full Text] [Related]
18. A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study.
Tsuchiya T; Kamohara R; Muraoka M; Nagayasu T; Saeki S; Takenoyama M; Suzuki M; Inada K; Tokunaga S; Hayashi T; Urabe S; Koga T; Akamine S; Sugio K
BMC Cancer; 2020 Dec; 20(1):1192. PubMed ID: 33276755
[TBL] [Abstract][Full Text] [Related]
19. Impact of adjuvant chemotherapy in completely resected stage IIIA non-small cell lung cancer.
Naim Younes R; Gross JL; Abrao FG; Rodrigues Pereira J
Minerva Chir; 2013 Apr; 68(2):169-74. PubMed ID: 23612230
[TBL] [Abstract][Full Text] [Related]
20. [Radio-chemotherapy combination in locally advanced, inoperable, non-small cell bronchial cancers].
Mornex F
Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S37-41. PubMed ID: 12538934
[No Abstract] [Full Text] [Related]
[Next] [New Search]